TREU JESSE I

CIK 000101342538 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001013425

Recent Transactions

50 trades

Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2020-06-09+2,465→ 2,465 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2020-06-09+26,503→ 26,503 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2020-06-09+2,311→ 2,311 total
Purchase
Vyome Holdings, Inc$HIND
Warrants to Purchase Common Stock
2019-08-06$4.00/sh+187,500→ 187,500 total
Purchase
Vyome Holdings, Inc$HIND
Common Stock
2019-08-06$4.00/sh+250,000→ 813,433 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2019-06-04+1,763→ 1,763 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2019-06-04+18,951→ 18,951 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2019-06-04+1,653→ 1,653 total
Sale
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2019-03-26$10.01/sh−445→ 8,763 total
Sale
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2019-03-26$10.01/sh−96,298→ 1,877,091 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2019-03-04$20.21/sh−414,958→ 1,231,647 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2019-03-04$20.21/sh−12,193→ 0 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2019-03-01$20.45/sh−272,977→ 1,646,605 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2019-03-01$20.45/sh−2,023→ 12,193 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2019-02-28$20.44/sh−319,619→ 1,947,375 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2019-02-28$21.24/sh−207→ 14,216 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2019-02-28$21.24/sh−27,793→ 1,919,582 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2019-02-28$20.44/sh−2,381→ 14,423 total
Conversion
Bionano Genomics, Inc.$BNGO
Series B-1 Preferred Stock
2018-08-23−22,161→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Series D Preferred Stock
2018-08-23−6,396,105→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Convertible Promissory Note
2018-08-23→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Series B-1 Preferred Stock
2018-08-23−2,986,762→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Common Stock
2018-08-23+4,386→ 4,386 total
Conversion
Bionano Genomics, Inc.$BNGO
Series D-1 Preferred Stock
2018-08-23−3,682,919→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Series B Preferred Stock
2018-08-23−50,532→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Series D-1 Preferred Stock
2018-08-23−27,328→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Series C Preferred Stock
2018-08-23−40,268→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Common Stock
2018-08-23+591,184→ 591,184 total
Conversion
Bionano Genomics, Inc.$BNGO
Common Stock
2018-08-23$4.59/sh+2,505→ 6,891 total
Conversion
Bionano Genomics, Inc.$BNGO
Common Stock
2018-08-23$4.59/sh+337,694→ 929,878 total
Purchase
Bionano Genomics, Inc.$BNGO
Warrants to Purchase Common Stock
2018-08-23+15,000→ 15,000 total
Purchase
Bionano Genomics, Inc.$BNGO
Common Stock
2018-08-23$6.13/sh+15,000→ 943,878 total
Conversion
Bionano Genomics, Inc.$BNGO
Convertible Promissory Note
2018-08-23→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Series B Preferred Stock
2018-08-23−6,810,098→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Series D Preferred Stock
2018-08-23−47,460→ 0 total
Conversion
Bionano Genomics, Inc.$BNGO
Series C Preferred Stock
2018-08-23−5,426,808→ 0 total
Purchase
Vyome Holdings, Inc$HIND
Common Stock
2018-08-23$1.82/sh+1,648,359→ 5,634,329 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2018-08-01$10.85/sh−119,112→ 2,266,994 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2018-08-01$10.85/sh−888→ 16,804 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2018-07-31$10.82/sh−377,188→ 2,386,106 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2018-07-31$10.82/sh−2,812→ 17,692 total
Award
VERACYTE, INC.$VCYT
Stock Option (Right to Buy)
2018-06-07+10,000→ 10,000 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2018-06-07+1,354→ 1,354 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2018-06-07+15,526→ 15,526 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2018-06-07+1,444→ 1,444 total
Conversion
Dicerna Pharmaceuticals Inc
Redeemable Convertible Preferred Stock
2017-12-18−49,632→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Common Stock
2017-12-18$3.19/sh+12,444→ 25,448 total
Conversion
Dicerna Pharmaceuticals Inc
Common Stock
2017-12-18$3.19/sh+1,678,432→ 3,431,139 total
Award
Dicerna Pharmaceuticals Inc
Common Stock
2017-12-18+37,890→ 3,469,029 total
Award
Dicerna Pharmaceuticals Inc
Common Stock
2017-12-18+282→ 25,730 total

Companies

Recent Filings

Address

C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE

PRINCETON, NJ, 08542

View on SEC.gov